- New Linguistic Validation product coming soon -

LVAgent™

Introducing LVAgent™

AI-powered innovation meets linguistic validation

A compliance-focused translation validation and content analysis tool for LV specialists

LVAgent™ Leadership

The Word Desk and Oxonova are joining forces to develop AI-powered LVAgent™. At the helm are a CEO and CTO who've worked together since 2017, combining deep expertise in cutting-edge tech for life sciences, particularly real-world evidence data capture and linguistic validation. We have the support of an awe-inspiring advisory board, keep scrolling down for more!

Advisors

Helen Williams DPhil

Chief Executive Officer

A linguistic validation expert with fifteen years' experience in global clinical trials and real world evidence data capture. Helen also has C-Suite experience in business operations.

Jon Spinage FBCS, CITP, AdvFEDIP, CHCIO

Chief Technology Officer

A Queen's Award for Enterprise-winning tech leader, known for building disruptive digital health SaaS and data-driven platforms and for his expertise in tech strategy roadmaps.

LVAgent™ Advisory Board

Our exceptional advisory board offers invaluable expertise in life sciences, technology, and business leadership. They have been trusted advisors to Helen and Jon for some time. Paul (affectionately known as PQ) was Helen's first boss back in 2010 at Oxford Outcomes! What a brilliant thing, to be working together again.

Paul Quarterman

Chair

Former Managing Director of Oxford Outcomes, a company that set the gold standard for patient-centered science and linguistic validation and was acquired by ICON plc in 2011.

Natalie Douglas

Advisor

A global business leader, non-exec director, and investor in life sciences, pharma services, digital, SaaS and data analytics, Natalie is a trailblazer in healthtech.

Mark Thackeray

Advisor

A renowned international entrepreneur with over thirty years experience in AI, ERP, Green Tech and IT sectors, Mark specialises in IT M&A.